{{Rsnum
|rsid=37022
|Gene=SLC6A3
|Chromosome=5
|position=1415514
|Orientation=minus
|GMAF=0.3448
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=SLC6A3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 7.7 | 32.3 | 60.0
| HCB | 13.3 | 62.2 | 24.4
| JPT | 11.4 | 65.9 | 22.7
| YRI | 19.0 | 52.4 | 28.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 13.3 | 62.2 | 24.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20091113
|Title=Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers
}}

{{PMID|17526637}} D2 dopamine receptor gene haplotypes and their influence on alcohol and tobacco consumption magnitude in alcohol-dependent individuals.

{{PMID|18444252|OA=1
}} Neurotransmission and bipolar disorder: a systematic family-based association study.

{{PMID|19673036|OA=1
}} Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population.

{{PMID|19693267|OA=1
}} Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}